Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.17B |
| 2 |
Apple
AAPL
|
+$849M |
| 3 |
Chevron
CVX
|
+$746M |
| 4 |
Synopsys
SNPS
|
+$643M |
| 5 |
Wells Fargo
WFC
|
+$633M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$517M |
| 2 |
Booking.com
BKNG
|
+$488M |
| 3 |
Walmart Inc
WMT
|
+$414M |
| 4 |
SNDK
Sandisk
SNDK
|
+$355M |
| 5 |
Cigna
CI
|
+$325M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.5% |
| 2 | Financials | 14.38% |
| 3 | Industrials | 14.2% |
| 4 | Consumer Discretionary | 10.53% |
| 5 | Healthcare | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
CF Bankshares
CFBK
$225M
| $1.61M | ﹤0.01% |
49,122
+10,474
| +27% | +$304K |
|
2752
Invesco S&P 500 Top 50 ETF
XLG
$10.8B
| $1.61M | ﹤0.01% |
26,274
-5,113
| -16% | -$312K |
|
2753
First Trust Value Line Dividend Fund
FVD
$8.3B
| $1.61M | ﹤0.01% |
33,378
-949
| -3% | -$45.2K |
|
2754
Protagonist Therapeutics
PTGX
$9.99B
| $1.61M | ﹤0.01% |
13,096
+1,222
| +10% | +$128K |
|
2755
NCR Voyix
VYX
$1.09B
| $1.61M | ﹤0.01% |
201,035
+59,719
| +42% | +$420K |
|
2756
Central Garden & Pet Co
CENT
$2.78B
| $1.6M | ﹤0.01% |
36,127
+10,186
| +39% | +$399K |
|
2757
Information Services Group
III
$239M
| $1.6M | ﹤0.01% |
388,980
+85,384
| +28% | +$357K |
|
2758
Hawkins
HWKN
$2.48B
| $1.6M | ﹤0.01% |
11,248
+1,034
| +10% | +$163K |
|
|
CGMM
2759
Capital Group U.S. Small and Mid Cap ETF
CGMM
$3.35B
| $1.6M | ﹤0.01% |
48,470
+27,863
| +135% | +$877K |
|
|
RZLV
2760
Rezolve AI
RZLV
$981M
| $1.59M | ﹤0.01% |
505,281
-381,779
| -43% | -$1M |
|
2761
Invesco KBW Bank ETF
KBWB
$6.75B
| $1.59M | ﹤0.01% |
17,115
+11,235
| +191% | +$983K |
|
2762
Goldman Sachs Physical Gold ETF Shares
AAAU
$2.8B
| $1.59M | ﹤0.01% |
40,098
+33,848
| +542% | +$1.51M |
|
2763
WisdomTree Dynamic International Equity Fund
DDWM
$1.5B
| $1.58M | ﹤0.01% |
34,293
| – | – |
|
|
EFXT
2764
Enerflex
EFXT
$2.48B
| $1.58M | ﹤0.01% |
64,399
+8,944
| +16% | +$223K |
|
|
OLP
2765
One Liberty Properties
OLP
$529M
| $1.58M | ﹤0.01% |
64,562
+17,970
| +39% | +$420K |
|
2766
Nektar Therapeutics
NKTR
$2.53B
| $1.57M | ﹤0.01% |
+22,542
| New | +$1.65M |
|
2767
Electromed
ELMD
$327M
| $1.57M | ﹤0.01% |
37,141
+22,471
| +153% | +$720K |
|
|
JPUS
2768
JPMorgan Diversified Return US Equity ETF
JPUS
$467M
| $1.57M | ﹤0.01% |
11,193
| – | – |
|
2769
Metallus
MTUS
$812M
| $1.57M | ﹤0.01% |
83,941
+26,268
| +46% | +$493K |
|
2770
GigaCloud Technology
GCT
$1.77B
| $1.57M | ﹤0.01% |
49,579
-7,116
| -13% | -$281K |
|
2771
VictoryShares Free Cash Flow ETF
VFLO
$10.5B
| $1.56M | ﹤0.01% |
34,107
-3,647
| -10% | -$159K |
|
2772
CRISPR Therapeutics
CRSP
$5.75B
| $1.56M | ﹤0.01% |
28,597
+6,329
| +28% | +$334K |
|
|
ATYR
2773
aTyr Pharma
ATYR
$49.2M
| $1.56M | ﹤0.01% |
2,610,548
+2,114,530
| +426% | +$1.38M |
|
|
AKTS
2774
Aktis Oncology
AKTS
$1.34B
| $1.55M | ﹤0.01% |
+48,123
| New | +$988K |
|
2775
Recursion Pharmaceuticals
RXRX
$1.88B
| $1.55M | ﹤0.01% |
422,087
+177,696
| +73% | +$592K |
|
Similar funds
Cliff Asness's Q2 2026 Portfolio in Review
As of Q2 2026, Cliff Asness held 3,986 positions worth $287B, up 31% from $218B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Cliff Asness deployed $37.5B of net new capital in Q2 2026, opening 247 new positions and adding to 2,455 existing holdings. Its largest new stake was FedEx Freight: 1,024,555 shares worth $155M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Micron Technology, an estimated $517M trimmed.
- Cliff Asness's largest Q2 2026 buy was FedEx Freight: 1,024,555 shares worth $155M.
- Cliff Asness added most to NVIDIA in Q2 2026, an estimated $1.17B increase.
- Cliff Asness's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $517M.
- Cliff Asness fully exited Masimo in Q2 2026, selling an estimated $147M.
- Cliff Asness's ten largest holdings make up 12% of its $287B portfolio in Q2 2026.
- Cliff Asness opened 247 new positions and closed 86 in Q2 2026.
- Cliff Asness's portfolio value rose 31% quarter-over-quarter to $287B.
Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.